On June 15th 2021, the 27 EU Health Ministers adopted the Council Conclusions on Access to Medicines and Medical Devices for a stronger and resilient EU, during a dedicated meeting that took place in Luxembourg.
On May 5th, the European Commission published an updated version of its Industrial Strategy, titled « Updating the 2020 New Industrial Strategy: Building a stronger Single Market for Europe’s Recovery ».
On February 18th 2021, the European Commission published its European Trade Strategy which aims at strengthening the EU’s trade policy to prepare for the world of 2030.
On November 25th 2020 ,the European Commission published its Intellectual Property (IP) Action Plan, which aims at taking stock of what has already been put in place and see how to further strengthen the EU’s IP framework to support the EU’s recovery and resilience.
On November 25th 2020, the European Commission published an inception impact assessment (IIA) evaluating proposals to review EU regulations for medicines for rare diseases and for children.
On November 25th 2020, the European Pharmaceutical strategy was published and presented by Commission Vice President Margaritis Schinas and Health Commissioner Stella Kyriakides.